Company Profile

NOVARTIS INDIA LTD.

NSE : NOVARTINDBSE : 500672ISIN CODE : INE234A01025Industry : TradingHouse : Novartis India - MNC
BSE819.85-13.65 (-1.64 % )
PREV CLOSE (Rs.) 833.50
OPEN PRICE (Rs.) 834.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1213
TODAY'S LOW / HIGH (Rs.)817.55 837.95
52 WK LOW / HIGH (Rs.)538.05 1099
NSE818.50 -16.65 (-1.99 % )
PREV CLOSE(Rs.) 835.15
OPEN PRICE (Rs.) 833.00
BID PRICE (QTY) 818.50 (20 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 9394
TODAY'S LOW / HIGH(Rs.) 816.05 840.55
52 WK LOW / HIGH (Rs.)530.05 1098

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 9.99658
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 4.61
ROCE (%) 6.67
Incorporation Year : 1947

Management Info :

C Snook - Chairman Sanjay Murdeshwar - Managing Director

Registered Office :

Address : The Inspire B K C, Part Of 601 & 701,Bandra Kurla Complex,Bandra East,
Mumbai,
Maharashtra-400051

Phone : 022-24958400 / 24958888/5024 3000

Website : www.novartis.in

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
30Jun06-30-2021$ Board Meeting Intimation for For Considering The Unaudited Financials Results For June Quarter. Board Meeting Intimation fo
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve the Unaudited financial results of the Company for the first quarter ending on June 30, 2021 ("said results").
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Boa..
18Jun06-18-2021$Novartis India informs about outcome of board meeting Novartis India informs about

In continuation to its letter dated May 11, 2021, Novartis India has informed that the Board of Directors of the Company has in its meeting held today, on Thursday, June 17, 2021 (‘said meeting’), have approved: Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2021, recommendation of final dividend of Rs 10 per Equity share of Rs 5 each for the year ended March 31, 2021, subject to approval of the shareholders of the Company, date for convening the 73rd Annual General Meeting of the shareholders of the Company is scheduled to be held on Friday, August 27, 2021 at 11:30 am through Video conference/ Other Audio Visual Means; and closure of Register of Members and Share Transfer books from Friday, August 20, 2021 to Friday, August 27, 2021 for determining the eligibility of shareholders for payment of Dividend. The said Meeting commenced at 11:00 am and concluded at 3.30 pm. Further, pursuant to Regulation 33 of the SEBI Listing Regulations, the company has enclosed: Audited Financial Results for the quarter and year ended March 31, 2021, Auditors Report dated June 17, 2021, issued by the Statutory Auditors of the Company with respect to the Audited Financial Results and taken on record by the Board of Directors of the Company and Declaration on unmodified opinion on Audit Report. The above is for the information and the same is also available on the Company's website: www.novartis.in.

The above information is a part of company’s filings submitted to BSE.

In continuation to its letter dated May 11, 2021, Novartis Indi..
17Jun06-17-2021$Novartis India informs about audited financial results Novartis India informs about

Novartis India has informed that the Board of Directors of the Company has in its meeting held today, on Thursday, June 17, 2021 (said meeting), have approved Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2021. Detailed outcome of the meeting is enclosed.

The above information is a part of company’s filings submitted to BSE.

Novartis India has informed that the Board of Directors of the..
17Jun06-17-2021$ Board recommends Final Dividend (AGM on August 27, 2021) Board recommends Final Divi
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 17, 2021, inter alia, have approved the following: - Recommendation of final dividend of Rs. 10/- per Equity share of Rs. 5/- each for the year ended March 31, 2021, subject to approval of the shareholders of the Company.
Novartis India Ltd has informed BSE that the Board of Directors..
11May05-11-2021$Novartis India informs about rescheduling of board meeting Novartis India informs about

In furtherance to letter dated March 31, 2021 with respect to the intimation of the meeting of the Board of Directors of the Company scheduled to be held on Thursday, May 20, 2021, Novartis India has informed that the said Board Meeting of the Company has been re-scheduled and will now be held on Thursday, June 17, 2021, to consider the Audited financial results of the Company for the fourth quarter and financial year ending on March 31, 2021 (‘said results’) and recommendation of final dividend on Equity Share, if any, for the said year. In this connection, further note that pursuant to the Company's Code of Conduct to regulate, monitor and report share trading by Insiders [‘the Code’], the trading window for dealing in securities of the Company which was earlier closed from Thursday, April 1, 2021 to Saturday, May 22, 2021 shall continue to remain closed till Saturday, June 19, 2021.

The above information is a part of company’s filings submitted to BSE.


In furtherance to letter dated March 31, 2021 with respect to t..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit62.8208.999999999999
Gross Profit 98.5 400.399999999999
Operating Profit 143598.799999999999
Net Sales 981.13813.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
The Yamuna Syndicate (BSE)
 17947.00 (12.09%)
M.Cap ( in Cr)
551.63
TCI Industries (BSE)
 1090.00 (3.95%)
M.Cap ( in Cr)
97.75
Halder Venture (BSE)
 732.50 (5.00%)
M.Cap ( in Cr)
231.52
Suumaya Corporation (BSE)
 1054.60 (1.31%)
M.Cap ( in Cr)
898.27
Cravatex (BSE)
 408.95 (2.08%)
M.Cap ( in Cr)
105.67
Shareholding Pattern More
PROMOTERS 70.68 %
NON-INSTITUTION 28.43 %
FI/BANKS/INSURANCE 0.77 %
MUTUAL FUNDS/UTI 0.07 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
Scheme NameHold(%)
Quant Small Cap Fund(G)0.19
F & O Quotes